Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson’s Disease – BRAIN SCIENCES

Santos-García, D; López-Manzanares, L; Muro, I; Lorenzo-Barreto, P; Peña, EC; García-Ramos, R; Valle, TF; Morata-Martínez, C; Baviera-Muñoz, R; Martínez-Torres, I; alvarez-Sauco, M; Alonso-Modino, D; Legarda, I; Valero-García, MF; Suárez-Muñoz, JA; Martínez-Castrillo, JC; Perona, AB; Salom, JM; Cubo, E; Valero-Merino, C; López-Ariztegui, N; Alonso, PS; Ponte, SN; Gónzález, EG; García, RM; Espinosa, R; Carmona, M; Feliz, CE; Ruíz, PG; Ruíz, TM; Rodríguez, BF; Alvarez-Santullano, MM – 2024 – 10.3390/brainsci14121244